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ABSTRACT
Changes in developmental regulatory programs drive both disease
and phenotypic differences among species. Linking human-specific
traits to alterations in development is challenging, because we have
lacked the tools to assay and manipulate regulatory networks in
human and primate embryonic cells. This field was transformed by
the sequencing of hundreds of genomes – human and non-human –
that can be compared to discover the regulatory machinery of genes
involved in human development. This approach has identified
thousands of human-specific genome alterations in developmental
genes and their regulatory regions. With recent advances in stem cell
techniques, genome engineering, and genomics, we can now test
these sequences for effects on developmental gene regulation and
downstream phenotypes in human cells and tissues.
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Introduction
Humans differ from chimpanzees, our closest living relatives, and
other mammals in a variety of traits, including disease
susceptibilities. Many of these differences have their origins in
development. The fossil record shows that some human traits, such
as the pelvic morphology associated with upright walking
(Harcourt-Smith et al., 2004), evolved around the time of
divergence from our common ancestor with chimpanzees about
six million years ago. Other traits, such as loss of a prominent brow
ridge (Lieberman, 2000), emerged only after modern humans split
from Neanderthals and other extinct hominins. Some phenotypes
are very recently evolved, as evidenced by variation between
modern human populations. These include pigmentation (Hancock
et al., 2011), keratinization (Gautam et al., 2015), hair texture
(Jablonski and Chaplin, 2014; Kamberov et al., 2013) and high
altitude adaptation (Huerta-Sanchez et al., 2014; Simonson et al.,
2010; Yi et al., 2010). For many distinctive traits, such as social
behaviors, symbolic thought and spoken language (Sterelny, 2011),
we have no evidence of the time period of evolution or only indirect
evidence from changes in the material culture left behind in the
archaeological record.
Collectively, human-specific traits have allowed our species to
dominate all climates and modify the landscape in a dramatic way
never seen in the history of life on earth. At the same time, our species
has acquired a unique profile of susceptibility to different diseases
compared with our close relatives. Some examples are AIDS (Varki
and Altheide, 2005), cardiovascular disease (Varki et al., 2009),
neurodegenerative disease (Finch, 2010) and psychiatric disorders
(Crow, 2000, 2007). Our high burden of neurological disease may be
an ‘Achilles heel’ associated with cognitive adaptations (Crow,
2000, 2007). To understand the evolutionary forces that shaped
human-specific traits and the molecular mechanisms through which
changes occurred, we must first track down the genetic alterations
underlying phenotypic differences between humans and our close
relatives. As in other species, the evolution of human-specific traits
must have emerged through genetic modification of developmental,
physiological or behavioral programs.
Development is a highly constrained and tightly regulated
process, orchestrated through complex gene regulatory networks
(Davidson and Erwin, 2006). There is a remarkable conservation of
development between organisms as evolutionarily distant as
cnidarians, insects and mammals. The same molecular pathways
control this conserved developmental program across animal
lineages. For example, humans, flatworms and cnidarians use the
same basic elements of paracrine signaling cascades, such as the
Wnt and TGFβ pathways (Finnerty et al., 2004; Carroll, 2005).
Transcription factors that regulate development are also highly
conserved, and they tend to regulate the same general processes in
diverse species, including regulation of body axis patterning by Hox
genes (Lemons and McGinnis, 2006), light-sensing organs by Pax6
(Gehring, 2011), head formation by Otx homologs (Yasuoka et al.,
2014) and heart morphology by Tinman/Nkx2-5 (Erwin, 1999).
This high level of conservation has allowed us to study human
development, despite limited access to human tissues for research,
using model organisms as proxies.
Conserved developmental programs, and hence morphology and
other traits, are modified through two primary mechanisms: direct
alterations to genes and thereby the functions of the encoded products
(proteins, RNAs), and changes in gene regulation (transcription,
splicing, translation, post-translational modifications). As most
developmental genes are pleiotropic and participate in multiple
independent developmental processes, their evolution is highly
constrained. By contrast, gene regulatory elements, including distal
enhancers (Pennacchio et al., 2006), tend to function in amore limited
number of cell types and stages, combining additively to control the
complex expression patterns of developmental genes (Noonan and
McCallion, 2010). This modularity makes gene regulation an ideal
template for the evolution ofmorphology (Carroll, 2008). Supporting
this idea, there ismounting evidence that human traits evolved largely
through genetic changes in regulatory regions (Haygood et al., 2010;
Horvath et al., 2014; McLean et al., 2011; Pollard et al., 2006a,b), as
initially proposed by King and Wilson (1975), although the relative
contributions of coding versus non-coding sequences continue to be
debated.
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In this Review, we discuss how genomics is transforming the
study of human developmental biology to enable direct analysis of
genetic variants that arose during human evolution in their native
context. The transformation started with genome sequencing and
the development of comparative genomic techniques for
pinpointing sequences, including both genes and regulatory
elements, that are unique to humans compared with chimpanzees
and other mammals. Although a few developmental genes have
been associated with the evolution of particular human-specific
traits (discussed further below), it has been more challenging to
characterize the role of regulatory sequences in human evolution
and disease. Functional genomics has helped to address this
challenge by generating rich information about the cell types and
developmental stages in which uniquely human sequences,
including non-coding sequences, function. By introducing human
variants of proteins and gene regulatory sequences into model
organisms and assaying their effects during embryogenesis, a
handful of human-specific sequences have been partially
characterized (reviewed by Devoy et al., 2012; Enard, 2014).
However, significant further work is needed to test the hypothesis
that these sequences altered traits during human evolution.
Fortunately, we are entering an era in which it is possible to
identify human-specific regulatory elements and to characterize
them functionally in human and non-human primate cells using
emerging techniques from stem cell biology and genome
engineering. Directly studying human development will accelerate
understanding of what makes our species unique.
The genome sequencing era
The availability of genome sequences for humans (International
Human Genome Sequencing Consortium, 2004), primates (The
Chimpanzee Sequencing and Analysis Consortium, 2005; Rhesus
Macaque Genome Sequencing and Analysis Consortium et al.,
2007), extinct hominins (Meyer et al., 2012; Prufer et al., 2014) and
many other vertebrates has fueled the discovery of human-specific
DNA sequences. Comparative genomic studies have cataloged three
general classes of genomic differences between humans and other
primates: large chromosomal alterations, smaller insertions and
deletions (indels), and single nucleotide substitutions (Fig. 1).
Developmental loci have accumulated polymorphic and fixed
differences of all three types during human evolution. Although the
catalog of human-specific differences is continually growing,
functional proof of how genetic changes translate into phenotypic
changes is scarce. In Table 1, we summarize select examples of
functional studies that have been undertaken in order to assess the
impact of human evolutionary changes. In a few cases, these studies
have illuminated the role that human-specific changes could have
had in the evolution of human traits, although a definitive causal
role in altering human phenotypes has yet to be established for any
of these human genomic regions.
Chromosomal alterations
Large genomic duplications, deletions and rearrangements (Fig. 1)
are relatively rare, but they encompass many developmental loci
owing to their size, which is usually thousands of base pairs (Coe
et al., 2014; Girirajan et al., 2011, 2013; Ma et al., 2006). For
example, segmental duplications are typically defined as regions
greater than one kilobase (kb) with >97% sequence identity
(Marques-Bonet et al., 2009). Human-specific structural variation
can be challenging to identify, because these loci are difficult to
assemble and align. They are therefore poorly represented in
genome assemblies, and their discovery often requires targeted
sequencing (Chaisson et al., 2015) and cytogenetic techniques. The
first structural differences between the human and chimp genomes
were discovered using chromatin-stained banding techniques and
include the fusion of two ancestral ape chromosomes to form human
chromosome 2, human-specific constitutive heterochromatin C
bands on chromosomes 1, 9, 16 and Y, and human-specific
pericentric inversions on chromosomes 1 and 18 (Yunis and
Prakash, 1982). Fluorescent in situ hybridization (FISH) and
comparative genomic hybridization (CGH) arrays identified >60
human-specific segmental duplications (Goidts et al., 2006; Jauch
et al., 1992; Wilson et al., 2006) and 152 genes displaying copy
number variation (Armengol et al., 2010; Fortna et al., 2004).
Many of these structural variants have altered gene expression or
downstream phenotypes in humans. The pericentric inversion of
chromosome 1, for example, is associated with human
developmental and neurogenetic diseases and contains copy
number increases of the developmental genes SLIT-ROBO Rho
GTPase activating protein (SRGAP2) (Box 1) (Dennis et al., 2012),
HYDIN (Doggett et al., 2006), and several DUF1220 domain-
containing gene families [e.g. the neuroblastoma breakpoint family
(NBPF)] (Fortna et al., 2004). This region demonstrates the complex
functional consequences of structural variants. The human-specific
duplication of the locus created two duplicate genes (SRGAP2B and
SRGAP2C). SRGAP2C dimerizes with the ancestral SRGAP2A and
phenocopies SRGAP2 inhibition, which appears to have led to
changes in radial neuron migration and cellular phenotypes
(discussed further in Box 1) (Charrier et al., 2012; Dennis et al.,
2012). Another interesting human-specific structural variant
occurred at chromosome 15q13-q14. This region contains
duplications of several genes, including ARHGAP11B, which is a
partial copy of the gene ARHGAP11A, truncated by the boundary of
the duplication.ARHGAP11B is expressed in the developing brain of
humans and appears to regulate brain development (Florio et al.,
2015). A polymorphic human-specific duplication also created the
salivary amylase gene AMY1, which probably enabled humans to eat
a high-starch diet (Perry et al., 2007) and is associated with obesity
(Falchi et al., 2014; but see Usher et al., 2015). Supporting the
adaptive role of duplications in human evolution (Iskow et al., 2012),
both coding (Hahn et al., 2007) and non-coding (Kostka et al., 2010)
elements in duplicated loci show signatures of positive selection.
Indels
Human-specific duplications and deletions of DNA shorter than one
kilobase are numerous and comprise ∼3.5% of the human genome,
most of which is non-coding (Britten, 2002; The Chimpanzee
Sequencing and Analysis Consortium, 2005; Varki and Altheide,
2005). They contribute more base pairs to human-chimp differences
than do individual DNA substitutions (see below), albeit fewer than
larger chromosomal alterations. Indels can have large functional
effects. Non-coding indels can alter human phenotypes by
modifying or completely deleting conserved developmental
enhancers (Table 1). A genome-wide survey revealed 510 highly
conserved sequences that were lost in humans, most of which were
non-coding, that included a forebrain subventricular zone enhancer
near the tumor suppressor gene GADD45G and a sensory vibrissae
and penile spine enhancer for the androgen receptor gene (McLean
et al., 2011) (Box 2). Additionally, retroelements resembling
transcription factor binding sites have expanded regulatory
networks in a variety of species (reviewed by de Souza et al.,
2013). Indels also affect genes, including changing the splicing,
reading frame, start or end of genes (Varki and Altheide, 2005).
These changes have generated many human-specific pseudogenes
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(Karro et al., 2007) and transcripts targeted to nonsense-mediated
decay (Lareau et al., 2007), including the loss of hundreds of
olfactory receptors during human evolution (Gilad et al., 2005;
Malnic et al., 2004). Quantifying rates and patterns of human-
specific chromosomal alterations and shorter indels is difficult,
despite the fact that their evolution can be modeled, because
estimation and inference with indel models is computationally
challenging (Chindelevitch et al., 2006; Diallo et al., 2007).
Additionally, indels are difficult to detect in whole-genome and
exome data (Fang et al., 2014). Thus, developing bioinformatics
methods for detecting indels and statistical tests for selection on
indels are important areas for future research.
Single nucleotide substitutions
The human and chimpanzee genomes differ by >30 million single
nucleotide substitutions (1.2% of the human genome), and slightly
less than half of these occurred on the human lineage, mostly in
non-coding DNA (The Chimpanzee Sequencing and Analysis
Consortium, 2005). Evolutionary theory posits that most
substitutions are nearly neutral and are therefore unlikely to have
produced uniquely human traits. To identify functional differences,
research performed before whole-genome sequencing focused on
non-synonymous changes to individual protein-coding sequences
(Dorus et al., 2004). The first genome-wide comparative genomic
analyses of humans and chimpanzees also focused on protein-
coding differences and revealed that genes involved in immunity,
sensory perception, and reproduction are enriched for positive
selection in humans (Brown et al., 2013; Clark et al., 2003; Nielsen
et al., 2005; Voight et al., 2006). Similar approaches, including ones
that incorporate population genetic data (Racimo et al., 2014), have
been used to identify genes that underwent selection after modern
humans diverged from Neanderthals and Denisovans (Meyer et al.,
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Fig. 1. Type of genetic and genomic changes and possible functional consequences. (A) Schematic of large chromosome rearrangements such as
duplications and deletions. Duplication of gene regions can lead to the appearance of new gene paralogs that can gain a new function after amino acid changes
(neofunctionalization or subfunctionalization), or be lost after deleterious mutations, leading to pseudogenization. By contrast, deletions of gene regions can lead
to loss of genes and regulatory elements. (B-F) Schematic of possible point mutation changes. (B) A non-synonymous change in the coding region of a gene
leading to change in the protein function. (C) A deleterious change such as a premature stop codon that can produce a truncated protein or pseudogene.
(D,E) Changes in repressor elements can lead to gain in expression domains for a gene (D), whereas mutations in an enhancer can produce gain, loss or
modification of gene expression patterns (E). (F) Mutations in insulators can lead to gain, loss or modification of expression domains as a result of unblocked
action of a distal enhancer on a target gene.
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Table 1. Candidate genes and regulatory regions underlying human phenotypic evolution
Gene or
element Mechanism of evolution Function
Associated human
phenotypic trait Caveats References
AMY1 Copy number variation;
increased copy
number in human
Encodes amylase, the enzyme
that degrades starch in the
mouth; in humans the amount
of amylase is dependent on the
number of copies of AMY1
Higher capability to
degrade starch in
humans; also
differences at the
human population
level
Evolutionary advantages of
having more AMY1 copies
is not clear, but may be
related to accessing novel
high-energy food sources
(e.g. tubers)
(Perry et al.,
2007)
ANC516/
HARE5
Accelerated evolution in
non-coding region
Non-coding element upstream of
the Wnt receptor gene Fzd8;
human and chimp HARE5
behave as nervous system
enhancers during mouse
development: chimp enhancer
displays weaker and later
activity; in mice, human-
HARE5::Fzd8 induced faster
progenitor cell cycle in the
developing brain and increased
neocortical size compared with
chimp-HARE5::Fzd8
Faster neural progenitor
cell cycle in humans
compared with
chimpanzee?
Insertion site and copy
number of human-HARE5::
Fzd8 and chimp-HARE5::
Fzd8 unknown – this could
influence phenotype; not
clear if FZD8 is in fact
differentially expressed in
human and chimpanzee
brains
(Bird et al., 2007;
Boyd et al.,
2015)
Androgen
receptor (AR)
enhancer
Deletion of regulatory
DNA
Mouse and chimp sequences
function as a developmental
enhancer in transgenic mice
driving expression of lacZ to
facial vibrissae and genital
tubercle
Loss of sensory
vibrissae and penile
spines
Regulation of AR expression
by enhancer not
demonstrated; not known if
loss of AR expression
causes loss of sensory
vibrissae and penile spines
(McLean et al.,
2011)
ARHGAP11A/B Human-specific
duplication
ARHGAP11A is a Rho GTPase
activating protein (GAP);
ARHGAP11B is a truncated
version that shows no GAP
activity; ARHGAP11B is
expressed in the developing
brain of humans; electroporation
in mouse neocortex induces
basal progenitor mitosis
Expansion of the human
neocortex?
Function of ARHGAP11B in
brain development is still
poorly understood
(Sudmant et al.,
2010; Florio
et al., 2015)
CMAH Pseudogene: CMAH
gene inactivated by
deletion of 92-bp
exon 6
CMAH is required for
biosynthesis of the sialic acid
Neu5Gc
Altered sialic acid
composition on all
cells
Physiological impact of the
absence of Neu5Gc in
human cells has not been
demonstrated
(Varki, 2010)
FOXP2 Two human-chimp
single nucleotide
substitutions subject
to positive selection
FoxP2 is a transcription factor;
R553H loss-of-function
mutation in human apparently
leads to apraxia/dyspraxia;
knock-in mouse with human-
specific FOXP2 mutations
displays developmental
defects (see Box 2)
Evolution of speech
capability?
Mutation in humans leading to
speech problems not same
as human-chimp
differences; no clear
connection between human-
specific substitutions in
FOXP2 and the evolution of
speech or language
(Hurst et al.,
1990; Lai et al.,
2001; Enard
et al., 2002;
Enard et al.,
2009)
Olfactory
receptors
Gene loss and
pseudogenization
Odor detection Loss of capability to
detect some odors?
Limited functional evidence of
odor detection gain or loss
with loss of genes
(Gilad et al., 2005;
Keller and
Vosshall, 2008)
SRGAP2 Copy number increase SRGAP2 is a RhoGAP important
in cortical development:
mutants show increased
neuronal branching;
SRGAP2B and C (truncated
human parologs) are expressed
in the developing cortex of
humans; SRGAP2C
heterodimerizes with
SRGAP2A and inhibits its effect
on neuronal spine maturation
Human-specific
changes in spine
morphology and
density – could have
implications for
cognition, learning and
memory?
Srgap2 knockout mice have
reduced viability;
differences in spine density
have not been found in the
cortex of human and
chimpanzees
(Dennis et al.,
2012; Charrier
et al., 2012;
Bianchi et al.,
2013)
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2012; Prufer et al., 2014). Several developmental genes that
acquired human-specific coding changes have been hypothesized to
be responsible for traits that changed during human evolution
(reviewed by Sikela, 2006; O’Bleness et al., 2012) (Table 1). These
include the forkhead transcription factor FOXP2, which is
associated with speech (Enard et al., 2002) and may have
undergone positive selection, although it is not clear if selection
targeted amino acid changes in the protein or nearby non-coding
substitutions (Ptak et al., 2009) (Box 3). Another trait that changed
significantly during human evolution is pigmentation. Several
regulators of pigmentation, including the ligand for the c-KIT
receptor (KITLG) (Sturm and Duffy, 2012), contain human-specific
protein-coding changes that may have evolved through positive
selection. Such examples are compelling, but additional work is
required to show that these genes are indeed responsible for
modification of the associated traits in humans.
As more vertebrates were sequenced, it became possible to use
models of DNA evolution to scan the whole human genome for
sequences that changed significantly more than expected by chance
since divergence from chimpanzees (Bird et al., 2007; Bush and
Lahn, 2008; Pollard et al., 2006b; Prabhakar et al., 2006a). To focus
on those changes outside coding portions of genes that have a high
probability to be functional, these studies analyzed regions that are
highly conserved in non-human species (mammals or vertebrates)
but significantly changed in humans. In the absence of functionally
annotated non-coding sequences, using this signature of negative
selection in other species helps to enrich for regulatory elements
with constrained function (Ovcharenko et al., 2004; Prabhakar et al.,
2006b; Schwartz et al., 2000; Siepel et al., 2005). These studies
collectively identified >2500 non-coding regions defined as ‘human
accelerated regions’ (HARs) (Hubisz and Pollard, 2014), most of
which show signatures of positive selection but some of which were
probably shaped by non-selective mechanisms, such as GC-biased
gene conversion or loss of constraint (Katzman et al., 2010; Kostka
et al., 2012; Pollard et al., 2006a; Ratnakumar et al., 2010;
Sumiyama and Saitou, 2011). Similar techniques have also been
used to analyze regions of the human genome that changed
significantly since divergence from extinct hominins (Green et al.,
2010). Interestingly, HARs are enriched for substitutions that pre-
date the divergence from Neanderthals and Denisovans, suggesting
that our genome did not evolve particularly rapidly during the
emergence of modern humans (Burbano et al., 2012; Hubisz and
Pollard, 2014). From a developmental perspective, HARs have a
particularly interesting genomic distribution: they cluster nearby
transcriptional factors and other regulatory genes expressed in
embryos (Capra et al., 2013; Kamm et al., 2013b), suggesting that
HAR mutations could be responsible for the evolution of human
traits through modification of developmental gene regulatory
networks.
Box 1. SRGAP2 – a highly duplicated gene
The gene SRGAP2 duplicated in a series of genomic events in the
lineage leading to Homo, between 3.4 and 1 million years ago (Dennis
et al., 2012). In humans, three additional, although partial, copies of this
gene are present: SRGAP2B, C and D (Charrier et al., 2012; Dennis
et al., 2012). The ancestral copy, present in all mammals, is named
SRGAP2A in humans and has been recently demonstrated to be
important in brain cortical development in mice (Guerrier et al., 2009).
TheSRGAP2 duplicates encode a truncated F-BAR domain that binds to
SRGAP2A and antagonizes its function during neuronal migration and
morphogenesis. The introduction of human-specific SRGAP2C in utero
in mouse pyramidal neurons induces a reduction in dendritic spine
heads, longer spine necks and higher spine density compared with
control neurons. In addition, it was found that mutant mice lacking
SRGAP2 display reduced width of dendritic spine heads, longer spine
necks and a higher density of dendritic spines (Charrier et al., 2012). So,
the expression of SRGAP2C mimics SRGAP2 deficiency during
neuronal migration, leading to a deficit in branching in the leading
process of migrating neurons and allowing neurons to reach their final
position in the cortical plate faster than control neurons. As dendritic
spines are known to enhance synaptic connectivity, enable linear
integration of synaptic inputs, and implement synapse specific plasticity
(Yuste, 2011), Charrier and colleagues (Charrier et al., 2012) speculate
that expression of SRGAP2C might allow human cortical pyramidal
neurons to receive and integrate a significantly higher number of synaptic
inputs without saturation, which could have important implications for
cognition, learning and memory. However, spine density in various
human and chimpanzee cortical regions is similar (Bianchi et al., 2013).
Charrier et al. (2012) also reported that Srgap2 knockout mice display
reduced viability, suggesting that loss of SRGAP2 activity might also
have detrimental consequences. Supporting this idea, a large genomic
alteration affecting the human ancestral SRGAP2A gene may be
responsible for the early-infantile encephalopathy and associated
epilepsy displayed in a patient (Saitsu et al., 2012). At this time, it is
not clear what human traits, if any, were directly affected by the
duplication of SRGAP2.
Box 2. Deletion of a conserved enhancer in the androgen
receptor locus
McLean and colleagues (McLean et al., 2011) discovered several non-
coding functional regions thatmay have played a role in human evolution.
They conducted a genome-wide search for conserved regions that were
lost in the human genome after divergence from chimpanzees. These
deleted regions are enriched near genes involved in steroid hormone
receptor signaling and neural function (McLean et al., 2011). They
decided to examine in detail a 60-kb human deletion downstream of the
androgen receptor (AR) locus. Within this human-specific deletion lies
an approximately 5-kb region that contains non-coding sequences that
are highly conserved in other mammals. The authors cloned the
corresponding chimpanzee and mouse regions and tested their
capacity to drive expression of an hsp68-lacZ reporter gene during
mouse development. Chimpanzee and mouse constructs both drove
consistent lacZ expression in the facial vibrissae and genital tubercle of
five or more independent transgenic embryos and the mouse sequence
also drove expression in hair follicles. Authors found that lacZ expression
was located in the mesoderm surrounding vibrissae follicles, and in the
superficial mesoderm within the presumptive glans of the developing
genital tubercle. Sixty-day-old transgenic mice showed expression in the
superficial tissue underlying epidermal spines of the penis (McLean
et al., 2011). Although previous studies have shown that AR is expressed
in mesenchyme surrounding developing epithelial structures (Crocoll
et al., 1998), colocalization studies of lacZ expression and AR would
confirm if the enhancer drives lacZ to a subset of AR expression
domains. It has been shown that humans lack micro- and macro-sensory
vibrissae, whereas chimpanzees havemicro-sensory vibrissae andmice
have both micro- and macro-vibrissae (Muchlinski, 2010). However, the
presence or absence of penile spines in humans and chimpanzees is
controversial (Reno et al., 2013). In addition, it has been shown that AR is
required for normal development of vibrissae, as castration shortens
vibrissae in mice, and excess testosterone increases growth (Ibrahim
and Wright, 1983). It has not been demonstrated that lack of vibrissae or
penile spines is caused by lack of AR expression in the vibrissae follicles
or developing penile spines. These results indicate that the human
deletion removes a conserved enhancer sequence that directs
expression in a subset of the AR expression pattern. However,
functional experiments are still required to test whether deletion of this
single enhancer can disrupt the formation of penile spines and vibrissae,
a molecular event that may help explain the phenotypic loss of these
structures in the human lineage.
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The next-generation sequencing era
Comparative genomics identifies uniquely human genome
sequences, but it does not tell us the cell types and developmental
stages in which a human-specific sequence functions, making it
challenging to link these genetic differences to human traits.
Additional data are needed to develop and test hypotheses about
themolecular and organismal phenotypes affected by human-specific
mutations. This gap is being rapidly filled by functional genomics
experiments that assay gene expression, epigenetic marks, protein-
DNA binding events, and three-dimensional interactions of
regulatory elements with gene promoters in many cell types and
species (Box 4). For genes with human-specific changes, functional
genomics has helped to shed light on tissue specificity,
developmental timing, and, in the case of regulatory genes,
downstream targets. For example, the gene network regulated by
FOXP2 (Box 3) is becoming clearer through identification of its
binding locations and DNA-binding motif (Nelson et al., 2013), as
well as studies of how FOXP2 mutations alter neuronal gene
expression (Konopka et al., 2009). These datasets lay the groundwork
for a deeper understanding of how FOXP2 might be involved in
language acquisition and, more broadly, human evolution.
Functional genomics has been crucially important for the study of
non-coding changes in the human genome (Sholtis and Noonan,
2010). First, it provides an alternative to simply relying on
evolutionary conservation to identify regulatory regions and
pinpoint changes that might affect them, which is important given
the dynamic turnover of regulatory DNA (Kunarso et al., 2010;
Rands et al., 2014). Functional genomics profiles can be
computationally integrated to identify different types of regulatory
sequences (promoters, enhancers, silencers and insulators;
Riethoven, 2010) that function in particular cell types and
developmental stages (Kellis et al., 2014). This approach provided
strong support for the hypothesis that non-coding HARs function as
gene regulatory elements (Hubisz and Pollard, 2014). A second use
of functional genomics data is to generate information about the
tissue- and stage-specificity of human-specific non-coding
sequences. Comparing chromatin states, transcription factor
binding profiles and gene expression across multiple cell types
predicts that one-third or more of HARs are gene regulatory
enhancers active in various embryonic tissues (Capra et al., 2013).
Such predictions can help identify the phenotypes inwhich a human-
specific non-coding mutation is involved (Trynka et al., 2013).
Functional genomics also provides a means to probe human and
non-human cells directly for differences in regulatory regions and
gene expression (Nowick et al., 2009; Somel et al., 2011), which
can then be traced back to genetic determinants. For example,
combined analysis of human and chimpanzee gene expression data
and sequences suggested that pain perception and nociception may
have changed in humans through differential regulation of opioid
signaling (Cruz-Gordillo et al., 2010). Comparative epigenetic
profiling of human, rhesus macaque and mouse corticogenesis
revealed promoters and enhancers that have gained activity during
human evolution (Reilly et al., 2015), although the sequence
differences driving these changes are yet to be identified. Similar
Box 3. The ‘speech gene’ FOXP2
The gene FOXP2 is one of the most extensively studied examples of a
uniquely human genome sequence. First, a family with severe speech
disabilities and an arginine-to-histidine substitution at position 553
(R553H) was identified (Hurst et al., 1990; Lai et al., 2001). To
understand the function of FOXP2 in humans, mouse models that
express the mutant form of FOXP2 present in affected members of the
family were generated (Groszer et al., 2008). The homozygotes were
severely developmentally delayed and died 3-4 weeks after birth. The
cerebellum was abnormally small, with decreased foliation, and,
behaviorally, the pups emitted fewer ultrasonic distress calls than did
heterozygotes or wild-type mice. Further analyses of the gene identified
two human-specific amino acid substitutions in comparison with
chimpanzee, gorilla and macaque [a threonine-to-asparagine
substitution at position 303 (T303N) and an asparagine-to-serine
substitution at position 325 (N325S)] with evidence of positive
selection (Enard et al., 2002). To investigate the phenotypic change
resulting from the two amino acid differences, mice with humanized
FOXP2 were generated and intensively studied (Enard et al., 2009).
These ‘humanized mice’ were fully viable and fertile, in contrast to the
R553H mouse model. They had no gross behavioral or anatomical
abnormalities but showed increased neuronal dendritic length, increased
synaptic plasticity and changes in ultrasonic vocalization in comparison
with wild-type mice (Enard et al., 2009). Despite the gigantic effort taken
to generate and study the consequences of the evolutionary changes in
human FOXP2, there is still no clear or direct connection between the
human-specific amino acid substitutions in FOXP2 and speech or
language. It is clear that mutations of FOXP2 in humans result in speech
impairments, indicating that FOXP2 plays a role in speech development,
but the nature of this role and whether the gene participated in the
evolution of language remain unknown.
Box 4. Assaying genome function across cell types
Functional genomics, broadly defined as sequencing experiments that
probe genome activity, helps to annotate and interpret uniquely human
DNA sequences in light of human development. To date, functional
genomics has mostly been applied to embryonic stem cells and other
homogenous cell cultures, although some embryonic tissues (Nord
et al., 2013; Visel et al., 2009) and developmental cell lines (Roadmap
Epigenomics Consortium et al., 2015; Romanoski et al., 2015) are being
studied. Several of the primary techniques are briefly defined here.
ChIP-seq. Chromatin immunoprecipitation coupled to sequencing
(Furey, 2012; Zentner and Henikoff, 2014) is used to generate genome-
wide maps of protein binding for transcription factors, structural proteins,
polymerases, and modified histones (The ENCODE Project Consortium,
2012; Roadmap Epigenomics Consortium et al., 2015; Vierstra et al.,
2014a). These binding events are integrated by computational methods
to predict regulatory elements and their activity. For example, enhancers
are associated with the acetyltransferase and transcriptional co-activator
p300 (Visel et al., 2009; Blow et al., 2010; Ghisletti et al., 2010), histone
H3 lysine 4 monomethylation (H3K4Me1) in the absence of significant
trimethylation (H3K4Me3) (Heintzman et al., 2007; Xi et al., 2007; Koch
et al., 2007), and combinations of transcription factor binding (Zinzen
et al., 2009). Additional chromatin modifications help to distinguish
active, inactive and poised enhancers (Rada-Iglesias et al., 2011).
Regulatory elements are frequently distal to the promoters they target
(Bulger and Groudine, 2011; Ong and Corces, 2011), making it hard to
predict the genes, pathways and phenotypes affected when they are
mutated.
Chromatin capture. Three-dimensional regulatory interactions can
be revealed by chromatin conformation capture (3C) and extensions
thereof (4C; Cullen et al., 1993; Dekker et al., 2002; Miele and Dekker,
2009) (5C, Hi-C; Dostie et al., 2006; Lieberman-Aiden et al., 2009; Rao
et al., 2014). The National Institutes of Health 4D Nucleome program
promises to produce a reliable three-dimensional map of many cell types
from humans andmodel organisms (Pennisi, 2015), and it should also be
possible to make maps for chimpanzees or other primates.
DNA methylation. Chemical modification of regulatory DNA that can
be assayed by a variety of techniques.
DNase-seq, FAIRE (formaldehyde-assisted isolation of
regulatory elements). Measurements of open chromatin associated
with regulatory elements (Buenrostro et al., 2013; He et al., 2014;
Vierstra et al., 2014b).
RNA sequencing. Quantifies gene expression; can also be used to
predict enhancers (Arner et al., 2015).
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investigations have compared patterns of open chromatin (Vierstra
et al., 2014a), associated with gene regulation, across tissues in
various humans and other mammals. However, most of these
studies do not include chimpanzee tissues, making it impossible to
pinpoint which of the identified differences occurred after the
human-chimpanzee divergence. Moreover, although these studies
provide a valuable catalog of differences between humans and other
mammals, more work is still required to understand how these
differences actually impact on human-specific phenotypes.
The power and limitations of transgenic model organisms
Efforts to characterize human-specific genes and non-coding
sequences functionally have primarily utilized mouse or zebrafish
models and low-throughput transgenic approaches. For example,
humanization of the Foxp2 gene in mice showed that the human
genotype leads to changes in learning (Schreiweis et al., 2014),
behavior, vocalizations and brain dopamine concentrations,
suggesting alterations to cortico-basal ganglia circuits (Enard
et al., 2009) (Box 2). Mouse models also play a large role in
studies of the functional effects of human-specific gene
duplications, including stimulation of mitosis in neocortical
progenitors by ARHGAP11B (Florio et al., 2015) (Table 1) and
antagonism of SRGAP2A function in neuronal spine maturation by
SRGAP2C (Charrier et al., 2012) (Box 1).
Transgenic animals can also be used to test non-coding sequences
hypothesized to play a role in human evolution. Reporter gene
assays allow candidate enhancers to be validated in mouse and
zebrafish embryos with transient transfections or stable lines (for
mouse examples, see Fig. 2). Enhancer activity has been
demonstrated for two conserved non-coding sequences deleted in
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Scale
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Fig. 2. Human accelerated regions (HARs) from human and chimp drive different expression patterns. Examples of HARs enhancer activity in transgenic
mouse reporter assays. (A) 2xHAR.114 is located on human chromosome 20 flanked by the genes FOXS1 and MYLK2. (B) 2xHAR.114 shows very high
conservation in mammals. (C,D) Schematics of the transgenes used to generate transgenic mice: sequences were cloned upstream of a minimal hsp68 promoter
and the reporter gene lacZ. (E,F) lacZ staining shows that both the chimpanzee (E) and the human (F) sequences produce consistent staining in the limbs (blue
arrows) as well as other regions, including spinal cord and developing brain of transgenic mice at E11.5, but the chimpanzee sequence drives expression to a
more extensive region in the limb (E; figure modified from Capra et al., 2013). (G) 2xHAR.142 is located on chromosome 14 in the fifth intron of the NPAS3 gene
where 13 other HARs have also been found. (H) 2xHAR.142 shows very high conservation in placental mammals. (I-L) Both chimpanzee (I) and human (J)
transgenes produce consistent staining in the hindbrain and spinal cord (red arrows) of transgenic mice at E12.5 (K and L, respectively), but only the human
sequence drives expression in the developing cortex (L, black arrow) (figure modified from Kamm et al., 2013a).
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humans – an androgen receptor enhancer (see Box 2) and a forebrain
enhancer upstream of GADD45G (McLean et al., 2011). Multiple
HARs have also been tested in this manner: HAR2/HANCS1
(which drives expression in the limb, pharyngeal arches, ear and
eye; Prabhakar et al., 2008); a cluster of 14 HARs near the gene
encoding the transcription factor NPAS3 (11 of which drive
expression in the nervous system; Kamm et al., 2013a); 23 HARs
tested by the VISTA Enhancer Browser project (17 in the nervous
system, three in limb, two in heart, eight in other tissues; Visel et al.,
2007); 29 HARs with epigenetic signatures of active developmental
enhancers (20 in the nervous system, eight in limb, four in heart,
eight in other tissues; Capra et al., 2013); and HARE5/ANC516
(Bird et al., 2007), a non-coding region located upstream of the Wnt
receptor frizzled 8 gene (FZD8) that is apparently neocortex specific
(Boyd et al., 2015). Supporting the hypothesis that human-specific
mutations in HARs may have altered their developmental regulatory
functions, several show expression differences between reporter
constructs carrying the chimpanzee and human HAR sequences
(Boyd et al., 2015; Capra et al., 2013; Kamm et al., 2013a,b;
Prabhakar et al., 2008). These include human gains of enhancer
activity for NPAS3-associated 2xHAR.142 in forebrain at
embryonic day (E) 12.5 (Kamm et al., 2013a) and for HAR2/
HANCS1 at the base of the limb bud at E11.5 (Prabhakar et al.,
2008), which may have resulted from the destruction of a repressor-
binding site (Sumiyama and Saitou, 2011). These studies aiming to
analyze the function of human-specific non-coding sequences and
then to study them comparatively in model organism enhancer
assays are adding valuable information about the possible
functional impact of human-specific DNA changes.
However, to demonstrate further the role of HARs in human
evolution will require additional studies of molecular and
organismal phenotypes. Boyd et al. (2015) took one step in this
direction in the functional study HARE5/ANC516 (Table 1). They
showed that the human enhancer is active earlier in forebrain
development than its chimpanzee ortholog, and then they generated
transgenic mice expressing the mouse Fzd8-myc tagged coding
region under the control of the human and chimpanzee HARE5
enhancer and analyzed them comparatively. They found that
human-HARE5-Fzd8 mice display faster progenitor cell cycles in
the developing brain and increased neocortical size compared with
mice in which Fzd8 is controlled by chimpanzee HARE5 or with
wild-type mice (Boyd et al., 2015). However, this study also
highlights several of the challenges of model organism transgenic
approaches. First, as the authors used random-insertion transgenic
mice and not locus-directed insertions of transgenes (Tasic et al.,
2011) or knock-in strategies, we do not know if the observed
phenotype is the result of differences between human and
chimpanzee HARE5 sequences or the number of insertions of
transgenes controlling Fzd8. In addition, analyzing overexpression
phenotypes is always challenging. Finally, studying human and
chimpanzee regulatory sequences or genes in mice is not guaranteed
to recapitulate their function in primates. There are important
differences between embryonic development in humans compared
with model organisms, including mice (Rossant, 2015), which
ultimately limit these studies to investigations of small pieces of the
human genome out of context.
The era of human development in a dish
Until recently, it was impossible to do genetics or apply functional
genomics techniques in developmentally relevant contexts in
humans, chimpanzees and other primates. Comparative studies at
the molecular and cellular level, therefore, have been mainly based
on analysis of preserved tissues from different adult organs
(frequently postmortem) or immortalized cell lines (Romero et al.,
2012; Schmidt et al., 2010; Zhou et al., 2014). Human embryonic
tissues and cells have also occasionally been utilized, for example in
the characterization of HAR1 (Pollard et al., 2006b) and SRGAP2
(Charrier et al., 2012; Dennis et al., 2012), and for comparative
epigenetic profiling (Reilly et al., 2015). However, the chimpanzee
samples necessary for determining whether observed differences are
human specific are not available.
Induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007)
and techniques allowing their in vitro differentiation into various
cell lines and tissues (reviewed by Karagiannis and Yamanaka,
2014; Yu et al., 2014) make it feasible to study and manipulate
developmental pathways in human and non-human primate cells
(Marchetto et al., 2013;Wunderlich et al., 2014). This is particularly
important for chimpanzees and other apes, for which we do not have
the same embryonic stem cell resources as we have for humans.
Various human and non-human primate cell types derived from
pluripotent lines have the potential to provide an unprecedented
view on how primate development unfolds at the molecular, cellular
and tissue level. Initial efforts in this direction compared gene
expression (Marchetto et al., 2013) and DNA methylation (Romero
et al., 2015) in iPSCs from multiple individuals of different species,
revealing rather limited differences between humans and non-
human primates in pluripotent cells. This approach will become
more relevant to human evolution and development as iPSCs are
differentiated into many cell types and additional functional
genomics assays are applied across developmental time courses in
multiple species (Fig. 3).
In recent years, there have been dramatic advances in our ability
to recapitulate organ growth in vitro, with culture techniques
moving away from monolayers of cells towards 3D cultures and
organoids, including of neural tissue, where many of human-
specific genetic variants appear to be most relevant (Lancaster and
Knoblich, 2014; Lancaster et al., 2013; Huch and Koo, 2015).
Human cell and organoid cultures are rapidly becoming central
tools for understanding human development and disease, and we
predict that this will soon also transform human evolutionary studies
by enabling direct comparisons of regulatory networks underlying
the control of tissue-specific developmental programs across
species or between genotypes engineered onto an isogenic human
or chimpanzee background (see below). These systems will
probably allow researchers to compare human and chimpanzee
tissues directly as they develop.
Future prospects
Although it is still early days for ‘human development in a dish’, the
emerging techniques discussed above, both in the cell culture and
the genomics fields, have enormous potential. As comparative
developmental studies using pluripotent cell line-derived cells and
tissues become routine, it will be exciting to see these approaches
applied to human and non-human primates in an effort to
reconstruct the genetic history of our species and connect
uniquely human genotypes to phenotypes. Other promising
approaches include proteomics, metabolomics and lipidomics,
which have already been leveraged to compare adult tissues and
cell lines across primates (Blekhman et al., 2014; Bozek et al., 2014,
2015; Khan et al., 2013). Another new method that is particularly
powerful for decoding regulatory networks is the massively parallel
reporter assay (MPRA), which is a high-throughput version of the
transgenic enhancer assay described above that is enabled by high-
fidelity DNA synthesis to make libraries of thousands of reporter
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constructs and low-cost RNA sequencing to assay enhancer activity
using unique transcribed sequences associated with each candidate
enhancer (Melnikov et al., 2012; Patwardhan et al., 2012). MPRA
libraries currently can only be introduced into cell lines or by tail-
vein injection into an adult mouse, and hence this technique has not
yet been applied to developing embryos. Nonetheless, MPRAs
promise to make screening human-specific non-coding sequences
for regulatory function (e.g. in organoids or developmental cell
types) much less laborious.
Potentially the most transformative breakthrough in human
evolutionary genomics will be genome editing [i.e. transcription
activator-like effector nucleases (TALENs), clustered regularly
interspaced short palindromic repeats (CRISPR)-Cas9] (Gilbert
et al., 2014; Zheng et al., 2014). Manipulating the genome to
introduce individual human mutations into non-human cells or to
knock out single human-specific elements in their native context,
and documenting resulting changes in phenotype, is the key to
demonstrating causality (Fig. 3). Moreover, such analyses can in
principle be carried out in the context of different specified cell
types using pluripotent stem cell differentiation protocols, at
different stages of development, and in a comparative manner
across multiple species. Coupled with other techniques, genome
editing can, in principle, help researchers to understand the
importance of every nucleotide in the human genome by
generating and testing different genotypes on an isogenic human
or non-human primate background. Editing is also accelerating the
generation of model organisms (e.g. mouse, zebrafish) carrying
humanized genome sequences to study in vivo the effects of genetic
changes on development and behavior.
Conclusions
To understand fully the differences between humans and
chimpanzees, and other mammals, we need to understand how
genetic differences impact on molecular and cellular mechanisms of
development leading to the morphological differences that separate
us. Comparative and population genomics enabled the identification
of thousands of genes and non-coding sequences that are uniquely
human. The availability of data about the cell types in which these
human-specific genotypes might be relevant allows us to develop
testable hypotheses about their roles in human evolution. However,
testing these hypotheses has proven to be quite challenging,
primarily because of the obvious limitations that we cannot perform
genetic manipulations to demonstrate causality or assay phenotypes
in humans or great apes, and appropriate human and primate tissues
for other studies are scarce. A handful of genes and regulatory
enhancers that were lost, duplicated or changed in humans have
been assayed for expression differences or other molecular and
organismal phenotypes, primarily in transgenic model organisms.
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Fig. 3. The present and future of comparative studies involving iPSC-derived cells and tissues from human and non-human primates. (A,B) iPSCs can
be derived from humans and other primates, including chimpanzees and bonobos, our closest living relatives. (C) This will allow the introduction of human-specific
variants into a non-human primate genomic context (or chimpanzee variants into a human genomic context), through genome editing. These variants could
then be screened for phenotypic effects at the molecular and cellular level. (D) In the near future, it will be also be possible to generate many differentiated
cell types from primate iPSCs as is already possible with human iPSCs, allowing comparative developmental studies. (E) In many cases, it should also be
possible to produce human and non-human primate organoids through tissue engineering techniques that will extend these studies to three-dimensions to
recapitulate embryonic development more accurately. (F) Different analysis methods, such as gene expression and epigenetic profiling, could be used to analyze
comparatively human and non-human differentiated cell types and organoids. RNA-sequencing image from Marchetto et al. (2013). All other pictures obtained
from image repositories that distribute them under creative commons licenses. Image credits: Bonobo head from Kabir; common chimpanzee in the Leipzig Zoo
from Thomas Lersch; human brain on white background from DJ.
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The majority of these are active in the developing brain, although
some function in limb, eye, heart and other tissues. Emerging
techniques for expanding such studies to human and non-human
primate organoids and developmental cell lines, coupled with
genomic techniques to increase their throughput, may be the key to
bridging the gap between uniquely human DNA and the
developmental events that produce the traits that are unique to our
species. We conclude that the field is now poised to decipher the
developmental pathways that translate human genetic changes into
human traits.
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Analysis of human accelerated DNA regions using archaic hominin genomes.
PLoS ONE 7, e32877.
Bush, E. C. and Lahn, B. T. (2008). A genome-wide screen for noncoding elements
important in primate evolution. BMC Evol. Biol. 8, 17.
Capra, J. A., Erwin, G. D., McKinsey, G., Rubenstein, J. L. R. and Pollard, K. S.
(2013). Many human accelerated regions are developmental enhancers. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 368, 20130025.
Carroll, S. B. (2005). Evolution at two levels: on genes and form. PLoS Biol. 3, e245.
Carroll, S. B. (2008). Evo-devo and an expanding evolutionary synthesis: a genetic
theory of morphological evolution. Cell 134, 25-36.
Chaisson, M. J. P., Huddleston, J., Dennis, M. Y., Sudmant, P. H., Malig, M.,
Hormozdiari, F., Antonacci, F., Surti, U., Sandstrom, R., Boitano, M. et al.
(2015). Resolving the complexity of the human genome using single-molecule
sequencing. Nature 517, 608-611.
Charrier, C., Joshi, K., Coutinho-Budd, J., Kim, J.-E., Lambert, N., de
Marchena, J., Jin, W.-L., Vanderhaeghen, P., Ghosh, A., Sassa, T. et al.
(2012). Inhibition of SRGAP2 function by its human-specific paralogs induces
neoteny during spine maturation. Cell 149, 923-935.
Chindelevitch, L., Li, Z., Blais, E. and Blanchette, M. (2006). On the inference of
parsimonious indel evolutionary scenarios. J. Bioinform. Comput. Biol. 4,
721-744.
Clark, A. G., Glanowski, S., Nielsen, R., Thomas, P. D., Kejariwal, A., Todd,
M. A., Tanenbaum, D. M., Civello, D., Lu, F., Murphy, B. et al. (2003). Inferring
nonneutral evolution from human-chimp-mouse orthologous gene trios. Science
302, 1960-1963.
Coe, B. P., Witherspoon, K., Rosenfeld, J. A., van Bon, B. W. M., Vulto-van
Silfhout, A. T., Bosco, P., Friend, K. L., Baker, C., Buono, S., Vissers, L. E. L.
M. et al. (2014). Refining analyses of copy number variation identifies specific
genes associated with developmental delay. Nat. Genet. 46, 1063-1071.
Crocoll, A., Zhu, C. C., Cato, A. C. B. and Blum, M. (1998). Expression of
androgen receptor mRNA during mouse embryogenesis. Mech. Dev. 72,
175-178.
Crow, T. J. (2000). Schizophrenia as the price that homo sapiens pays for language:
a resolution of the central paradox in the origin of the species. Brain Res. Brain
Res. Rev. 31, 118-129.
Crow, T. J. (2007). Nuclear schizophrenic symptoms as the key to the evolution of
the human brain. In Evolution of Nervous Systems (ed. J. Kaas), pp. 549-567.
Oxford, UK: Elsevier.
Cruz-Gordillo, P., Fedrigo, O., Wray, G. A. and Babbitt, C. C. (2010). Extensive
changes in the expression of the opioid genes between humans and
chimpanzees. Brain Behav. Evol. 76, 154-162.
Cullen, K. E., Kladde, M. P. and Seyfred, M. A. (1993). Interaction between
transcription regulatory regions of prolactin chromatin. Science 261, 203-206.
Davidson, E. H. and Erwin, D. H. (2006). Gene regulatory networks and the
evolution of animal body plans. Science 311, 796-800.
de Souza, F. S. J., Franchini, L. F. and Rubinstein, M. (2013). Exaptation of
transposable elements into novel cis-regulatory elements: is the evidence always
strong? Mol. Biol. Evol. 30, 1239-1251.
Dekker, J., Rippe, K., Dekker, M. andKleckner, N. (2002). Capturing chromosome
conformation. Science 295, 1306-1311.
Dennis, M. Y., Nuttle, X., Sudmant, P. H., Antonacci, F., Graves, T. A., Nefedov,
M., Rosenfeld, J. A., Sajjadian, S., Malig, M., Kotkiewicz, H. et al. (2012).
Evolution of human-specific neural SRGAP2 genes by incomplete segmental
duplication. Cell 149, 912-922.
Devoy, A., Bunton-Stasyshyn, R. K. A., Tybulewicz, V. L. J., Smith, A. J. H. and
Fisher, E. M. C. (2012). Genomically humanized mice: technologies and
promises. Nat. Rev. Genet. 13, 14-20.
Diallo, A. B., Makarenkov, V. and Blanchette, M. (2007). Exact and heuristic
algorithms for the Indel Maximum Likelihood Problem. J. Comput. Biol. 14,
446-461.
Doggett, N. A., Xie, G., Meincke, L. J., Sutherland, R. D., Mundt, M. O., Berbari,
N. S., Davy, B. E., Robinson, M. L., Rudd, M. K., Weber, J. L. et al. (2006). A
360-kb interchromosomal duplication of the human HYDIN locus. Genomics 88,
762-771.
Dorus, S., Vallender, E. J., Evans, P. D., Anderson, J. R., Gilbert, S. L.,
Mahowald, M., Wyckoff, G. J., Malcom, C. M. and Lahn, B. T. (2004).
Accelerated evolution of nervous system genes in the origin of Homo sapiens.Cell
119, 1027-1040.
Dostie, J., Richmond, T. A., Arnaout, R. A., Selzer, R. R., Lee,W. L., Honan, T. A.,
Rubio, E. D., Krumm, A., Lamb, J., Nusbaum, C. et al. (2006). Chromosome
Conformation Capture Carbon Copy (5C): a massively parallel solution for
mapping interactions between genomic elements. Genome Res. 16, 1299-1309.
Enard, W. (2014). Mouse models of human evolution. Curr. Opin. Genet. Dev. 29,
75-80.
Enard, W., Gehre, S., Hammerschmidt, K., Hölter, S. M., Blass, T., Somel, M.,
Brückner, M. K., Schreiweis, C., Winter, C., Sohr, R. et al. (2009). A humanized
version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 137, 961-971.
Enard, W., Przeworski, M., Fisher, S. E., Lai, C. S. L., Wiebe, V., Kitano, T.,
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